drugset / Trial / NCT06145269
Recanalization Rate of Acute DVT
Non-randomizedParallel-groupSingle-blindTreatment
Summary
Rporting and evaluation of the rate of recanalization of acute DVT of the lower limb at one year follow-up comparing the results of using NOACs vs. conventional treatment.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2025-04-01
- Completion
- 2025-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rivaroxaban | Other / unclassified | 20 mg | Oral |
| Comparator | Warfarin | Small molecule | 5 mg | Oral |